TERRA-HOMEPAGE-resized

Grounded in science, elevating the standard

We are a global cannabinoid company, committed to growth through scientific innovation and operational integrity.

ABOUT TERRASCEND


TerrAscend provides quality products, brands, and services to the global cannabinoid market. As the first North American Operator (NAO), with scale operations in both Canada and the US, the Company participates in the medical and legal adult use market across Canada and in several US states where cannabis has been legalized for therapeutic or adult use. Additionally, TerrAscend will soon be the first and only cannabis company with sales in the US, Canada, and Europe as it has received EU GMP certification for its manufacturing facility in Mississauga, Ontario. TerrAscend operates a number of synergistic businesses, including The Apothecarium, an award-winning cannabis dispensary with several retail locations in California and Nevada; Arise Bioscience Inc., a manufacturer and distributor of hemp-derived products; Ascendant Laboratories Inc., a biotechnology and licensing company committed to the continuous improvement of cannabinoid expressing plants; Solace RX Inc., a proposed Drug Preparation Premises (DPP) focused on the development of novel formulations and delivery forms; and Valhalla Confections, a manufacturer of premium cannabis-infused edibles.

SUBSIDIARIES & BRANDS


The Apothecarium

The Apothecarium is recognized as one of the nation’s premier dispensaries. Their mission is to provide guests quality cannabis products in a welcoming environment with empathy, education and ongoing personal support to patients and consumers.

Founded by three cousins and two family friends in 2011, the dispensary is known for providing free cannabis education events to the public and in-depth one-on-one consultations from highly trained cannabis consultants.

The Apothecarium’s flagship San Francisco dispensary was named one of the best designed dispensaries in the country by Architectural Digest.

Arise Bioscience

Arise Bioscience is an industry leader in the production and distribution of hemp-derived health and wellness products, with access to over 10,000 retail locations worldwide.

Through extensive research, product development, and innovative production capabilities, Arise is focused on advancing world’s perception of the hemp CBD industry though familiar brands consumers trust.

Terrascend

TerrAscend Canada

TerrAscend Canada Inc., a licensed cannabis producer under the Cannabis Act, provides medical cannabis to patients through its online medical marketplace Solace Health.

TerrAscend Canada Inc. also participates in the adult-use market in Canada through direct and indirect supply agreements in several provinces.

solacehealth

Solace Health

Solace Health is the Online Marketplace for Licensed Producer, TerrAscend Canada Inc. Solace Health provides patients a unique one-stop-shop for all of their medical cannabis product and accessory needs. Solace Health aims to be the choice of patients through its friendly and convenient on-boarding and shopping experience.

Solace Health provides same-day home delivery in the GTA, support for Veteran patients, and Compassionate Care Pricing. Whether it is finding the right product for your needs or help on how to consume, Solace Health is here to provide assistance at your finger tips.

shnclinic

Solace Health Network

Solace Health Network is a network of support programs for patients and healthcare practitioners seeking medical cannabis treatment, education, and coverage.

SHN supports each patient from initial contact through to verified medical authorization, helping to maneuver through barriers and reduce any confusion along the way.

Solace Health Network leverages a wealth of knowledge from the pharmaceutical industry and a vast network of allied health professionals to provide uncomplicated medical cannabis access to patients across Canada.

Solace Rx

Our industry’s first Drug Preparation Premises (DPP) facility will allow TerrAscend the ability to innovate and produce specialized pharmaceutical products for healthcare professionals and institutions. Solace Rx will deliver formulations that will address unmet medical needs where no commercial product is otherwise available.

Solace Rx further positions TerrAscend as a leading medical cannabis company in the field of personalized medicine. Operations of Solace Rx are scheduled to launch in 2019. For more information, contact Mike Hannalah, President & Co-Founder, at info@solacerx.com.

Valhalla

Valhalla is a provider of leading premium edible products, which are currently available for sale in California, Nevada, and New Mexico.

Valhalla’s handcrafted artisan gummies are creatively inspired and offer precise dosing and even distribution while regularly engaging third-party labs to independently certify potency and purity.

With strain specific options available in three great tasting flavors, the high-quality gummies are kosher, gluten-free, and made with organic ingredients, all while maintaining eco-friendly practices.

Valhalla was formed in 2014 in connection with The Apothecarium principals.

HavenSt

Haven St.

Premium Cannabis

Invented by the innovative, crafted by the curious, and expanded by the explorers. Here, every door leads to experience and discovery waits around every corner.

Find inner peace. Reset your soul. Focus your mind. Escape to slumber. Rise to unbelievable sensation. Each block on Haven St. is a new experience to discover, and every address delivers a new variation.

Whoever you are, wherever you’re going, Haven St. can take you there. Explore Responsibly.

Must be of legal age to consume our products.

Knüba Naturals

Knüba Naturals is a premium medical cannabis brand under TerrAscend Canada. Knüba Naturals focuses on utilizing a variety of cultivation techniques, growing environments, and genetics to provide patients with the utmost choice and product variety.

With a team backed by pharmaceutical experience and a dedication to quality, Knüba Naturals strives to deliver high-quality cannabis products to meet a wide range of patient needs and enhance patient outcomes.

TEAM


Executive Leadership Team

Michael Nashat — CEO, Co-Founder and Director

TerrAscend’s co-founder and CEO, Dr. Michael Nashat, Pharm. D., has over 12 years of experience in patient care, quality assurance, medical and regulatory affairs and R&D. Prior to co-founding TerrAscend, Dr. Nashat cofounded and was the Executive Director of OnPharm Independent Pharmacy Group, the largest independent non banner group in Canada with over 500 pharmacies. Dr. Nashat is a former board member of the Canadian Association of Chain Drug Stores, Ontario College of Pharmacists and the Canadian Foundation for Pharmacy. Dr. Nashat is a former member of the Ontario Ministry of Health and Long Term Care’s Pharmacy Council and the former Vice Chair of the Ontario Pharmacists Association’s Owners Advisory Council. Dr Nashat received his Doctor of Pharmacy Magna Cum Laude from the Albany College of Pharmacy and Health Sciences and completed his Post-Doctoral Fellowship in Neuroscience Medical Strategy at Rutgers University and Bristol-Myers Squibb.

Matthew Johnson — President

Matthew Johnson, a seasoned healthcare industry executive with over 25 years of experience, has held multiple senior-level positions with several large medical device and pharmaceutical companies. Most recently, he led the AbbVie Transition Office and was responsible for managing enterprise-wide transformation efforts, including merger integration. Prior to this, he headed Global Alliance Management within Abbott’s pharmaceuticals division where he drove collaboration strategy planning, alignment and communication among project teams for all of Abbott’s partnered pipeline products. He also held senior leadership roles at Brunswick Corporation and Baxter Healthcare Corporation.

Adam Kozak — Chief Financial Officer

Adam Kozak brings a wealth of experience from Loblaw Companies Limited.  During his 10-year tenure, Adam led initiatives in mergers and integration, process re-engineering and analytics. Prior to Loblaw, Adam also held positions at Deloitte and Wormald Masse Keen Lopinski.

Stacey Schulte — EVP, Communications & Brand Strategy

Stacey has over 20 years of experience in marketing, communications, brand strategy, M&A integration, operations, and change management. She is inspired by companies that are values-driven and committed to having a positive impact on the world. She joined TerrAscend in April 2019, following over a decade of senior communications roles at McKinsey & Company. She has experience working in a wide range of industries, including architecture and engineering, fashion design, and financial services.

Brian Feldman — General Counsel

Brian has 20+ years of experience serving in investment transactional advisory, securities regulation, and compliance. Prior to joining TerrAscend, Brian held positions at Sound Point Capital Management and Fried Frank, Harris, Shriver & Jacobson.

Business Team

Robyn Rabinovich — VP, Cannabis Strategy and Partnerships

Robyn Rabinovich is a business development professional with extensive experience in the cannabis space. Her knowledge supports her ability to evaluate business development opportunities within Canada and across the globe. Robyn obtained her International Business Degree from Dalhousie University.

Ari Unterman — VP, Business Development

Ari Unterman was formerly a corporate lawyer with experience in corporate and technology law. He has also participated in entrepreneurial and start up ventures, including supporting an early stage legal technology start up. Ari obtained his BA in Political Science at Western University and his JD/MBA at the University of Windsor.

Board of Directors

Jason Wild — Chairman

Jason Wild is the President and Chief Investment Officer of JW Asset Management, LLC, and the advisor for five investment partnerships with approximately $1 billion in assets under management. Mr. Wild received his license as a pharmacist in 1997, and subsequently founded JW Asset Management, LLC in 1998. The firm has a strong history of finding opportunities within the healthcare sector. He is a graduate of the Arnold and Marie Schwartz College of Pharmacy. Mr. Wild is the Chairman of the Board of TerrAscend Corp. and Arbor Pharmaceuticals. He is a board member of Vensun Pharmaceuticals and Vitruvias Therapeutics. Funds managed by JW Asset Management, LLC are the largest shareholders in TerrAscend Corp. Mr. Wild is also a board member of NETA NJ LLC where he will be actively involved in planning and directing the organization’s strategic and long-range goals.

Michael Nashat — CEO, Co-Founder and Director

TerrAscend’s co-founder and CEO, Dr. Michael Nashat, Pharm. D., has over 12 years of experience in patient care, quality assurance, medical and regulatory affairs and R&D. Prior to co-founding TerrAscend, Dr. Nashat cofounded and was the Executive Director of OnPharm Independent Pharmacy Group, the largest independent non banner group in Canada with over 500 pharmacies. Dr. Nashat is a former board member of the Canadian Association of Chain Drug Stores, Ontario College of Pharmacists and the Canadian Foundation for Pharmacy. Dr. Nashat is a former member of the Ontario Ministry of Health and Long Term Care’s Pharmacy Council and the former Vice Chair of the Ontario Pharmacists Association’s Owners Advisory Council. Dr Nashat received his Doctor of Pharmacy Magna Cum Laude from the Albany College of Pharmacy and Health Sciences and completed his Post-Doctoral Fellowship in Neuroscience Medical Strategy at Rutgers University and Bristol-Myers Squibb.

Richard Mavrinac — Director

Richard Mavrinac held positions as CFO for George Weston Limited and Executive VP of Loblaw Companies and has extensive expertise in public company finance and strategy.

Craig Collard — Director

Craig Collard is the CEO of Veloxis Pharmaceuticals, a commercial-stage specialty pharmaceutical company committed to improving the lives of transplant patient and has over 20 years of experience in the pharmaceutical industry. Mr. Collard has a proven track-record of leadership, managing organizational change, and driving successful merger and acquisition activity. Prior to Veloxis, Mr. Collard was the Founder and CEO of Cornerstone Therapeutics, a company focused on hospital, respiratory and adjacent specialty markets.

Lisa Swartzman — Director

Lisa has 20+ years of experience in manufacturing, distribution, and retail, previously holding senior financial positions with some of Canada’s largest publicly-traded corporations. A strategic thinker with diverse experience in leading growth, Lisa has advised mid-market privately held companies in both the United States and Canada. Lisa holds a BA (Economics) from Western University, and an MBA from Queen’s University, and also holds the Institute of Corporate Directors ICD.D (Certified Director) designation.

INVESTOR CENTRE


Press Releases & News

Download our Investor Presentation
Background

Follow TER:CSEand TRSSF:OTCQX
Stay tuned for updates and news

BUSINESS DEVELOPMENT


Hello! We want to learn about your business, discuss your need for investment and explore opportunities to work together.  Please share your non-confidential information on the form below and we’ll be in touch.



CANADIAN FACILITY


Built to GMP requirements

TerrAscend-icon-1

67,300 sq ft facility strategically located in Mississauga

TerrAscend-icon-2-v2

Premium hydroponic cultivation

TerrAscend-icon-3

Sterile & non-sterile drug compounding capabilities

TerrAscend-icon-4

Lab tested to the highest standards

CAREERS


We’re growing fast and looking for top talent to join our team. Click on a link below to submit your application.

Background